Long-term Safety of Ampreloxetine in Patients with Symptomatic Neurogenic Orthostatic Hypotension

Authors
Category Primary study
Conference2024 International Congress of Parkinson's Disease and Movement Disorders
Year 2024
This article has no abstract
Epistemonikos ID: dfa38be4ce54659891ab2b6b0e7fcb68857efc92
First added on: Jan 10, 2026